A multicenter prospective observational study of the conformity of temozolomide prescriptions in France. (Record no. 21624333)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02105 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516082933.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201212s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1099-1557 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1002/pds.3233 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Tilleul, Patrick |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20121210 |
245 00 - TITLE STATEMENT | |
Title | A multicenter prospective observational study of the conformity of temozolomide prescriptions in France. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Pharmacoepidemiology and drug safety |
Date of publication, distribution, etc. | Aug 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 828-34 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents, Alkylating |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Combined Modality Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dacarbazine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Utilization |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | France |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glioma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Guideline Adherence |
General subdivision | statistics & numerical data |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Off-Label Use |
General subdivision | statistics & numerical data |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Practice Guidelines as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Practice Patterns, Physicians' |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Temozolomide |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brignone, Melanie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hassani, Yasmine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Labrande, Christelle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pedeboscq, Stéphane |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gensollen, Sophie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lahille, Benedicte |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Exinger, Delphine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bertholle, Valérie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Billard, Martine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Charlety, Dominique |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Prebay, Danielle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pinguet, Frederic |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Taillibert, Sophie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cartalat, Stéphanie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chinot, Olivier |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Borget, Isabelle |
773 0# - HOST ITEM ENTRY | |
Title | Pharmacoepidemiology and drug safety |
Related parts | vol. 21 |
-- | no. 8 |
-- | p. 828-34 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1002/pds.3233">https://doi.org/10.1002/pds.3233</a> |
Public note | Available from publisher's website |
No items available.